Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Molecular Image

Out of Business LATEST DEAL TYPE

Operator of a personalized-medicine software company intended to develop new methods to image cancer and neurologic diseases. The company's technology offers Magnetic Resonance Imaging data which is used for predictive molecular diagnostics for multiple sclerosis and other important diseases, enabling doctors to non-invasively measure the levels of specific molecules inside the brain to provide a quantitative risk score for disease progression and thereby influence disease management plans.

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • 1165 Monte Rosa Drive
  • Menlo Park, CA 94025
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Molecular Image’s full profile, request a free trial.

Molecular Image Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jan-2015 00000 Completed Out of Business
1. Angel (individual) 31-Jan-2006 00000 00000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Molecular Image Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
% Owned
Series A 00,000,000 00.00 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

Molecular Image Executive Team (1)

Name Title Board
Jay Wohlgemuth Founder & President